Macitentan (Opsumit)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Macitentan (Opsumit), covering 2018-02-05 to 2018-02-05. Get the full timeline:
Most recent: Clinical Trial Update: A Pulmonary Arterial Hypertension Study With Macitentan to Validate the PAH-SYMPACT™ in France, Italy and Spain [Phase 3]